Zoetis share price today

(ZTS)

Zoetis share price is $177.17 & -₹177.17 as on 12 Dec 2024, 2.30 'hrs' IST

$177.17

▲

0.46

(0.26%)

Market is closed - opens 8 PM, 12 Dec 2024

View live Zoetis share price in Dollar and Rupees. Guide to invest in Zoetis from India. Also see the sentimental analysis on Indian investors investing in Zoetis. Get details on the Indian mutual funds that are investing in Zoetis. Get Analyst recommendations and forecasts along with all the Zoetis's financials.

Zoetis share price movements

$176.13
$178.25
$177.17
0.59%
Downside
Day's Volatility :1.19%
Upside
0.61%
$144.80
$201.92
$177.17
18.27%
Downside
52 Weeks Volatility :28.29%
Upside
12.26%

Zoetis Returns

Period	Zoetis Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-7.34%	-7.5%	0.0%
6 Months	3.15%	-1.3%	0.0%
1 Year	-10.49%	7.9%	0.0%
3 Years	-23.95%	7.1%	-20.0%

Zoetis Key Statistics

in dollars & INR

Previous Close	$176.71
Open	$176.26
Today's High	$178.25
Today's Low	$176.125
Market Capitalization	$79.7B
Today's Volume	$1.5M
52 Week High	$201.92
52 Week Low	$144.8
Revenue TTM	$9.2B
EBITDA	$3.8B
Earnings Per Share (EPS)	$5.33
PE Ratio	33.15
Dividend Yield	0.97%
Profit Margin	26.55%
Quarterly Earnings Growth YOY	0.16%
Return On Equity TTM	47.3%

How to invest in Zoetis from India?

It is very easy for Indian residents to invest directly in Zoetis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zoetis stock in both rupees (INR) and dollars (USD). Search for Zoetis or ZTS on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zoetis or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zoetis shares which would translate to -0.000 fractional shares of Zoetis as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Zoetis

-28%

Period: Sep 12, 2024 to Dec 11, 2024. Change in 30 Days versus previous period

Search volume for Zoetis on INDmoney from India has reduced in the last 30 days as on Dec 12, 2024. -28% less investors are searching Zoetis in the last 30 days versus the previous period.

Indian Mutual Funds that own Zoetis

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	3893	-55.20	0.15%

Global Institutional Holdings in Zoetis

Vanguard Group Inc
9.14%
BlackRock Inc
8.16%
State Street Corp
4.38%
State Farm Mutual Automobile Ins Co
3.55%
AllianceBernstein L.P.
3.41%
Bank of America Corp
3.18%

Analyst Recommendation on Zoetis

Buy

86%Buy

13%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Zoetis(by analysts ranked 0 to 5 stars)

Based on 22 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Zoetis

What analysts predicted

Upside of 20.91%

Current:

$177.17

Target:

$214.22

Insights on Zoetis

Price Movement
In the last 3 months, ZTS stock has moved down by -7.3%
Increasing Revenue
Zoetis Inc. has shown positive revenue growth over the last three quarters. The revenue increased from $2.19 billion to $2.38 billion, averaging an increase of 4.2% each quarter.
Increasing Net Profit
Zoetis Inc. has demonstrated strong profit growth over the last four quarters. Their net profit has increased from $525.0 million to $682.0 million, averaging an increase of 8.3% each quarter.
ZTS vs CTLT (1 yr)
In the last 1 year, Catalent, Inc. has given 66.9% return, outperforming this stock by 74.6%
Price to Sales
Zoetis Inc. has a Price-to-Sales Ratio of 8.8, meaning investors are willing to pay $8.8 for every $1 of sales the company generates. In contrast, Catalent, Inc. has a much lower Price-to-Sales Ratio of 2.6, indicating that investors are only willing to pay $2.6 for every $1 of sales. This suggests that Zoetis Inc. is valued significantly higher by investors relative to its sales compared to Catalent, Inc.

Zoetis Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$5.8B	↑ 9.76%
Net Income	$1.4B	↑ 65.28%
Net Profit Margin	24.52%	↑ 8.24%

	FY19	Y/Y Change
Revenue	$6.3B	↑ 7.47%
Net Income	$1.5B	↑ 5.04%
Net Profit Margin	23.96%	↓ 0.56%

	FY20	Y/Y Change
Revenue	$6.7B	↑ 6.63%
Net Income	$1.6B	↑ 9.2%
Net Profit Margin	24.54%	↑ 0.58%

	FY21	Y/Y Change
Revenue	$7.8B	↑ 16.49%
Net Income	$2.0B	↑ 24.36%
Net Profit Margin	26.2%	↑ 1.66%

	FY22	Y/Y Change
Revenue	$8.1B	↑ 3.91%
Net Income	$2.1B	↑ 3.78%
Net Profit Margin	26.16%	↓ 0.04%

	FY23	Y/Y Change
Revenue	$8.5B	↑ 5.74%
Net Income	$2.3B	↑ 10.88%
Net Profit Margin	27.43%	↑ 1.27%

	Q2 FY23	Q/Q Change
Revenue	$2.2B	↑ 9.0%
Net Income	$671.0M	↑ 21.56%
Net Profit Margin	30.78%	↑ 3.18%

	Q3 FY23	Q/Q Change
Revenue	$2.2B	↓ 1.33%
Net Income	$596.0M	↓ 11.18%
Net Profit Margin	27.71%	↓ 3.07%

	Q4 FY23	Q/Q Change
Revenue	$2.2B	↑ 2.88%
Net Income	$525.0M	↓ 11.91%
Net Profit Margin	23.72%	↓ 3.99%

	Q1 FY24	Q/Q Change
Revenue	$2.2B	↓ 1.04%
Net Income	$599.0M	↑ 14.1%
Net Profit Margin	27.35%	↑ 3.63%

	Q2 FY24	Q/Q Change
Revenue	$2.4B	↑ 7.81%
Net Income	$624.0M	↑ 4.17%
Net Profit Margin	26.43%	↓ 0.92%

	Q3 FY24	Q/Q Change
Revenue	$2.4B	↑ 1.14%
Net Income	$682.0M	↑ 9.29%
Net Profit Margin	28.56%	↑ 2.13%

	FY18	Y/Y Change
Total Assets	$10.8B	↑ 25.52%
Total Liabilities	$8.6B	↑ 26.35%

	FY19	Y/Y Change
Total Assets	$11.5B	↑ 7.13%
Total Liabilities	$8.8B	↑ 2.85%

	FY20	Y/Y Change
Total Assets	$13.6B	↑ 17.88%
Total Liabilities	$9.8B	↑ 11.3%

	FY21	Y/Y Change
Total Assets	$13.9B	↑ 2.14%
Total Liabilities	$9.4B	↓ 4.88%

	FY22	Y/Y Change
Total Assets	$14.9B	↑ 7.37%
Total Liabilities	$10.5B	↑ 12.46%

	FY23	Y/Y Change
Total Assets	$14.3B	↓ 4.28%
Total Liabilities	$9.3B	↓ 11.66%

	Q2 FY23	Q/Q Change
Total Assets	$13.7B	↓ 0.04%
Total Liabilities	$9.1B	↓ 1.46%

	Q3 FY23	Q/Q Change
Total Assets	$14.1B	↑ 2.6%
Total Liabilities	$9.0B	↓ 1.05%

	Q4 FY23	Q/Q Change
Total Assets	$14.3B	↑ 1.28%
Total Liabilities	$9.3B	↑ 2.91%

	Q1 FY24	Q/Q Change
Total Assets	$14.3B	↑ 0.43%
Total Liabilities	$9.3B	↑ 0.01%

	Q2 FY24	Q/Q Change
Total Assets	$14.2B	↓ 1.28%
Total Liabilities	$9.2B	↓ 0.98%

	Q3 FY24	Q/Q Change
Total Assets	$14.4B	↑ 1.36%
Total Liabilities	$9.1B	↓ 0.89%

	FY18	Y/Y Change
Operating Cash Flow	$1.8B	↑ 32.99%
Investing Cash Flow	$-2.3B	↑ 736.67%
Financing Cash Flow	$533.0M	↓ 312.35%

	FY19	Y/Y Change
Operating Cash Flow	$1.8B	↑ 0.28%
Investing Cash Flow	$-504.0M	↓ 77.69%
Financing Cash Flow	$-951.0M	↓ 278.42%

	FY20	Y/Y Change
Operating Cash Flow	$2.1B	↑ 18.44%
Investing Cash Flow	$-572.0M	↑ 13.49%
Financing Cash Flow	$123.0M	↓ 112.93%

	FY21	Y/Y Change
Operating Cash Flow	$2.2B	↑ 4.09%
Investing Cash Flow	$-458.0M	↓ 19.93%
Financing Cash Flow	$-1.9B	↓ 1613.82%

	FY22	Y/Y Change
Operating Cash Flow	$1.9B	↓ 13.6%
Investing Cash Flow	$-883.0M	↑ 92.79%
Financing Cash Flow	$-904.0M	↓ 51.45%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$183.0M	↓ 66.67%
Investing Cash Flow	$-80.0M	↓ 62.96%
Financing Cash Flow	$-494.0M	↓ 72.59%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$724.0M	↑ 295.63%
Investing Cash Flow	$-567.0M	↑ 608.75%
Financing Cash Flow	$-416.0M	↓ 15.79%

Zoetis Technicals Summary

Sell

Neutral

Buy

Zoetis is currently in a neutral trading position according to technical analysis indicators.

Zoetis Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Zoetis Inc.	1.58%	3.15%	-10.49%	-23.95%	39.74%
Neurocrine Biosciences Inc.	1.54%	-5.36%	4.38%	56.49%	18.54%
Haleon Plc Spon Ads	4.2%	14.03%	17.78%	30.5%	30.5%
Viatris Inc.	-3.25%	20.4%	23.49%	-0.32%	-23.44%
Catalent, Inc.	5.05%	11.2%	56.97%	-50.16%	17.19%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Zoetis Inc.	33.15	33.15	2.48	5.88	0.47	0.15	0.01	11.59
Neurocrine Biosciences Inc.	34.48	34.48	0.3	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.44	28.44	1.72	0.34	0.07	0.04	0.02	1.82
Viatris Inc.	224.4	NA	0.08	2.67	-0.04	0.02	0.04	16.58
Catalent, Inc.	211.02	NA	518.67	0.2	-0.11	0.0	NA	19.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Zoetis Inc.	Buy	$79.7B	39.74%	33.15	26.55%
Neurocrine Biosciences Inc.	Buy	$13.1B	18.54%	34.48	17.21%
Haleon Plc Spon Ads	Buy	$43.7B	30.5%	28.44	10.75%
Viatris Inc.	Hold	$15.1B	-23.44%	224.4	-5.87%
Catalent, Inc.	Hold	$11.3B	17.19%	211.02	-9.34%

Zoetis Dividend announcements

Zoetis Dividends December, 2024
In the quarter ending December,2024. Zoetis has declared dividend of $0.43
Read More

About Zoetis

Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.

Organization	Zoetis
Employees	14100
CEO	Ms. Kristin C. Peck
Industry	Health Technology

Management People of Zoetis

Name	Title
Ms. Kristin C. Peck	CEO & Director
Mr. Wetteny N. Joseph CPA	Executive VP & CFO
Ms. Wafaa Mamilli	EVP & Group President for China, Brazil and Preci. Animal Health
Dr. Robert J. Polzer Ph.D.	Executive VP and President of Research & Development
Mr. Keith Sarbaugh	Executive VP & Chief Digital and Technology Officer
Mr. Steven Frank	Vice President of Investor Relations
Ms. Roxanne Lagano	Executive VP, General Counsel & Corporate Secretary
Mr. William Price	VP & Chief Communications Officer
Ms. Julie A. Fuller	Executive VP, Chief Human Resources Officer & Global Operations
Ms. Jeannette Ferran Astorga	Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer

Important FAQs about investing in Zoetis from India :

What is Zoetis share price today?

Zoetis (ZTS) share price today is $177.17.

Can Indians buy Zoetis shares?

Yes, Indians can invest in the Zoetis (ZTS) from India.

With INDmoney, you can buy Zoetis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Zoetis at zero transaction cost.

How can I buy Zoetis shares from India?

It is very easy to buy Zoetis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zoetis be purchased?

Yes, you can buy fractional shares of Zoetis with INDmoney app.

What are the documents required to start investing in Zoetis stocks?

To start investing in Zoetis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.